作者: Eduardo S. Cardoso , Bernardo M. Rodrigues , Marcelo Barroso , Carla J. Menezes , Rita S. Lucena
DOI: 10.1016/J.PEDIATRNEUROL.2005.08.010
关键词: Physical medicine and rehabilitation 、 Spasticity 、 Spastic 、 Tizanidine 、 Gait analysis 、 Randomized controlled trial 、 Physical therapy 、 Botulinum toxin 、 Baclofen 、 Cerebral palsy 、 Medicine
摘要: Muscle overactivity, one of the cardinal features spasticity, is a common sequel cerebral palsy. In this group patients spasticity responsible for several limitations that interfere with gait, causing variable functional disability. Drugs such as baclofen, tizanidine, or benzodiazepines, even definitive treatments orthopedics neurosurgeries are generally prescribed uncertain results. The use botulinum toxin type A has been frequently suggested treatment spastic equinus foot in palsy, but few studies adequate methodology support idea. present paper reviews and summarizes data published double-blind, randomized clinical trials to assess, meta-analysis, if an caused by results reveal statistical superiority over placebo on gait improvement, tested using Physician Rating Scale Video Gait Analysis (Peto odds ratio = 3.99, 95% confidence interval 2.20-7.22) foot. also presented better subjective assessment than 3.49, 1.50-8.12). Adverse events were more observed after A, they considered mild self-limited.